ALEXANDRIA, Va. – The Journal of Clinical Oncology (JCO) is celebrating the publication of its 500th issue. The tri-monthly peer-reviewed journal of the American Society of Clinical Oncology (ASCO) will reach this milestone with its November 10, 2009, edition.
The inaugural, 72-page issue of the JCO published in January of 1983. Today, the journal publishes more than 500 pages of peer-reviewed studies, editorials, commentaries and guidelines each month, reaching a subscribership of nearly 25,000. The JCO also publishes 15 international editions, reaching thousands of readers in both English and their native languages. JCO’s impact factor, the measure of how frequently a journal’s articles are cited, has risen to a current, highest-ever rating of 17.157, with annual citations at an all-time high of 97,639. On average, research published in JCO is cited in other peer-reviewed journals every six minutes.
“This quincentenary edition of JCO is indicative of the quality and longevity the journal has shown in the worldwide dissemination of significant clinical oncology research,” said Daniel G. Haller, MD, Editor-in-Chief of JCO. “We look forward to continue to improve our efforts in being a credible, authoritative resource to the oncology community.”
# # #
About the American Society of Clinical Oncology
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 27,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. Patient-oriented cancer information is available at www.cancer.net.
About the Journal of Clinical Oncology
The Journal of Clinical Oncology is the tri-monthly peer-reviewed journal of the American Society of Clinical Oncology (ASCO), the world's leading professional society representing physicians who treat people with cancer. For more information, please visit www.jco.org.